Description
126602-89-9
Quinupristin-dalfopristin
Virginiamycin M1, 26-((2-(diethylamino)ethyl)sulfonyl)-26,27-dihydro-, (26R,27S)-, mixt. with 4-(4-(dimethylamino)-N-methyl-L-phenylalanine)-5-(5-((1-azabicyclo(2.2.2)oct-3-ylthio)methyl)-4-oxo-L-2-piperidinecarboxylic acid)virginiamycin S1
Virginiamycin S1, 4-(4-(dimethylamino)-N-methyl-L-phenylalanine)-5-((2S)-5-((1-azabicyclo(2.2.2)oct-3-ylthio)methyl)-4-oxo-2-piperidinecarboxylic acid-, mixt. with (3R,4R,5E,10E,12E,14S26R,26aS)-26-((2-(diethylamino)ethyl)sulfonyl)-8,9,14,15,24,25,26,26a-octahydro-14-hydroxy-4,12-dimethyl-3-(1-methylethyl)-3H-21,18-nitrilo-1H,22H-pyrrolo(2,1-c)(1,8,4,19)dioxadiazacyclotetracosine-1,7,16,22(4H,17H)-tetrone
RP-59500
Synercid
Dalfopristin - quinupristin mixt.
Quinupristin - dalfopristin mixt
Dalfopristin mixture with Quinupristin
Quinupristin and dalfopristin
RP 59500 (CAS 126602-89-9) reference standard, produced by CATO (ISO 17034 / CNAS / ANAB accredited). Molecular formula: C53H67N9O10S C34H50N4O9S. Trusted by 10,000+ laboratories worldwide for pharmaceutical analysis and QC.